| Revenue growth | 6% YoY growth to ₹88.5 crore in FY26. |
|---|---|
| Margins | EBITDA margins expanded 330bps to 37.5% via efficiency. |
| Demand visibility | Strong demand in B2C and government PPP segments in NCR. |
| Management confidence | Balanced, though slightly defensive regarding regulatory delays and missed targets. |
Growth
FY26 revenue grew 6%; EBITDA margins improved to 37.5% due to operating leverage and favorable mix.
Outlook
Guidance of 25-30% revenue growth for FY27; ₹20-25 crore capex planned for expansion.
Risks
Prolonged regulatory approval cycles for diagnostic equipment and high concentration of slow-paying government receivables.
Earnings Call filed with BSE, BSE: 544482. Summary written with AI assistance from the document.
Star Imaging and Path Lab Ltd: key numbers
- Share price
- ₹77.70
- Market cap
- ₹135.3 Cr
- Revenue (annual)
- ₹88.53 Cr
- Net profit (annual)
- ₹19.28 Cr
- P/E (TTM)
- 7.0×Sector 57.8×
- Promoter holding
- 71.92%
- FII holding
- 0.61%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Star Imaging and Path Lab Ltd
All →Star Imaging and Path Lab Earnings Call: Key Takeaways
Star Imaging reported FY26 revenue of ₹88.5cr (up 6%) and PAT of ₹19.3cr (up 21%). Management focuses on B2C expansion and becoming debt-free.
Star Imaging and Path Lab Earnings Call: Key Takeaways
Star Imaging reports FY26 revenue of ₹88.5cr (+6% YoY) and PAT of ₹19.3cr (+21% YoY). Strategy focuses on PPP models and expanding B2B networks.
Star Imaging and Path Lab H2 FY26 Results: Net Profit ₹9.2 Cr, Down 5.2% YoY
Star Imaging and Path Lab Ltd reported revenue from operations of ₹43.3 Cr (+5.9% YoY) and net profit of ₹9.2 Cr (-5.2% YoY) for H2 FY26.
- Key figure
- Net profit ₹9.2 Cr · -5.2% YoY